This activity includes patient counseling videos.
Program Description
Hereditary angioedema (HAE) is a serious, potentially fatal disease of intermittent and recurring swelling that typically occurs in an individual’s limbs and face, as well as the gastrointestinal tract and airways. The current recommended treatment for HAE includes a combination of on-demand and short- and/or long-term prophylactic treatment to reduce the number of life-threatening attacks; however, use of prophylaxis depends on the frequency and severity of attacks, potential adverse effects of different medications, the cost of treatment, and the route and schedule of administration. As accessible members of the health care community, pharmacists play a vital role in not only the identification of HAE, but referrals for treatment and monitoring medications for efficacy and adverse effects. Through this activity, pharmacists will become equipped to help patients overcome treatment barriers and improve patient outcomes through education regarding new and emerging therapies for HAE.
Target audience: Specialty pharmacists
Type of activity: Application
Release date: July 31, 2023
Expiration date: October 23, 2023
Time to complete activity: 1.0 hour
Learner level: Foundational
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Discover the burden and quality of life implications of hereditary angioedema (HAE)
- Explore the importance of early diagnosis and prompt intervention, including prophylaxis and on-demand acute medications
- Examine the safety and efficacy of current and emerging therapies for HAE
- Identify the role of pharmacists in improving outcomes for patients with HAE through collaboration with the multidisciplinary team and patient education
David Frame, PharmD
Clinical Immuno-Hematology and Cell Therapy Specialist
Assistant Professor
Department of Clinical Pharmacy
University of Michigan College of Pharmacy
Ann Arbor, Michigan
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-23-301-L01-P. The activity is available for CE credit through October 23, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
David Frame, PharmD, has the following financial relationship with a commercial interest to disclose:
Grant/Research Support: Jazz Pharmaceuticals
The following contributors have no relevant financial relationships with commercial interests to disclose:
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Michelle C. Carlson, PharmD; Angelica Archibald; Susan Pordon; Brianna Winters; and Chloe Taccetta.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms